Titration of biologically active amyloid-β seeds in a transgenic mouse model of Alzheimer's disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Morales, Rodrigo ^a,b   Bravo Alegria, Javiera ^a,b   Duran Aniotz, Claudia ^a   Soto, Claudio ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL; BRAIN; DISEASE MODEL; FEMALE; MALE; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC;

EID: 84928034534     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09349     Document Type: Article

References (34)

1. Mucke, L. & Selkoe, D. J. Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2, a006338 (2012).
2. Cleary, J. P. et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. (2004).
3. Takahashi, R. H. et al. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592-3599 (2004).
4. Schenk, D., Basi, G. S. & Pangalos, M. N. Treatment strategies targeting amyloid beta-protein. Cold Spring Harb. Perspect. Med. 2, a006387 (2012).
5. Klein, W. L. Synaptotoxic amyloid-beta oligomers: Amolecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? J. Alzheimers. Dis. 33 Suppl 1, S49-S65 (2013).
6. Soto, C. Unfolding the role of Protein Misfolding in Neurodegenerative Diseases. Nature Rev. Neurosci. 4, 49-60 (2003).
7. Prusiner, S. B. Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383 (1998).
8. Soto, C., Estrada, L. & Castilla, J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31, 150-155 (2006).
9. Jarrett, J. T. & Lansbury, P. T. Jr. Seeding one-dimensional crystallization'' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058 (1993).
10. Soto, C. Transmissible Proteins: Expanding the Prion Heresy. Cell 149, 968-977 (2012).
11. Kane, M. D. et al. Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J. Neurosci. 20, 3606-3611 (2000).
12. Meyer-Luehmann, M. et al. Exogenous induction of cerebral betaamyloidogenesis is governed by agent and host. Science 313, 1781-1784 (2006).
13. Eisele, Y. S. et al. Peripherally Applied A{beta}-Containing Inoculates Induce Cerebral {beta}-Amyloidosis. Science 330, 980-982 (2010).
14. Watts, J. C. et al. Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc. Natl.Acad. Sci. U.S.A. 108, 2528-2533 (2011).
15. Morales, R. et al. De novo induction of amyloid-beta deposition in vivo. Mol. Psychiatry 17, 1347-1353 (2012).
16. Stohr, J. et al. Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc. Natl. Acad. Sci. U.S.A. 109, 11025-11030 (2012).
17. Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913 (2009).
18. Iba, M. et al. Synthetic tau fibrilsmediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J. Neurosci. 33, 1024-1037 (2013).
19. Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953 (2012).
20. Duran-Aniotz, C. et al. Brains from non-Alzheimer's individuals containing amyloid deposits accelerate Abeta deposition in vivo. Acta Neuropathol. Commun. 1, 76 (2013).
21. Rosen, R. F. et al. Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats. J. Neurochem. 120, 660-666 (2012).
22. Kimberlin, R. H. & Walker, C. A. Pathogenesis of scrapie (strain 263 K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67 (Pt 2), 255-263 (1986).
23. Morales, R. et al. Reduction of prion infectivity in packed red blood cells. Biochem. Biophys. Res. Commun. 377, 373-378 (2008).
24. Duran-Aniotz, C. et al. Aggregate-depleted brain fails to induce abeta deposition in a mouse model of Alzheimer's disease. PLoS One 9, e89014 (2014).
25. Walker, L., LeVine, H. & Jucker, M. Koch's postulates and infectious proteins. Acta Neuropathol. (Berl) (2006).
26. Petkova, A. T. et al. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262-265 (2005).
27. Watts, J. C. et al. Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc. Natl. Acad. Sci. U.S.A. 111, 10323-10328 (2014).
28. Stohr, J. et al. Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice. Proc. Natl. Acad. Sci. U.S.A. 111, 10329-10334 (2014).
29. Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
30. Saa, P., Castilla, J. & Soto, C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281, 35245-35252 (2006).
31. McLean, A. R. & Bostock, C. J. Scrapie infections initiated at varying doses: An analysis of 117 titration experiments. Philos. Trans. R. Soc. Lond B Biol. Sci. 355, 1043-1050 (2000).
32. Eisele, Y. S. et al. Induction of cerebral beta-amyloidosis: Intracerebral versus systemic Abeta inoculation. Proc. Natl. Acad. Sci. U.S.A. 106, 12926-12931 (2009).
33. Eisele, Y. S. et al. Multiple Factors Contribute to the Peripheral Induction of Cerebral beta-Amyloidosis. J. Neurosci. 34, 10264-10273 (2014).
34. Deleault, N. R. et al. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U.S.A. 109, E1938-E1946 (2012).